Kingsbury Capital Investment Advisors LLC Matinas Bio Pharma Holdings, Inc. Transaction History
Kingsbury Capital Investment Advisors LLC
- $65.6 Million
- Q3 2022
A detailed history of Kingsbury Capital Investment Advisors LLC transactions in Matinas Bio Pharma Holdings, Inc. stock. As of the latest transaction made, Kingsbury Capital Investment Advisors LLC holds 119,949 shares of MTNB stock, worth $63,572. This represents 0.12% of its overall portfolio holdings.
Number of Shares
119,949
Previous 119,949
-0.0%
Holding current value
$63,572
Previous $95,000
20.0%
% of portfolio
0.12%
Previous 0.13%
Shares
1 transactions
Others Institutions Holding MTNB
# of Institutions
6Shares Held
3.52MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.48MShares$1.32 Million0.0% of portfolio
-
Jtc Employer Solutions Trustee LTD775KShares$410,7500.0% of portfolio
-
Hyman Charles D79.8KShares$42,2940.0% of portfolio
-
Sawtooth Solutions, LLC60KShares$31,8080.0% of portfolio
-
Ifp Advisors, Inc643Shares$3400.0% of portfolio
About Matinas BioPharma Holdings, Inc.
- Ticker MTNB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,864,992
- Market Cap $115M
- Description
- Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...